Slide Naga, the good results you, overall start everyone. summarizes our I'll to Thank X, on for fourth morning which quarter. and
we quarter fourth sales the year's weeks fourth acquisitions, increase to final of from from X% of million. included acquisition quarter the sales growth were $XXX from X% up contribution Atrion the XXXX prior compared ARAG You'll million, see also but in recent $XXX the acquisition, prior The the year. that primarily completed
each and fourth segments bit Fluid in These moment. organic our Medical within and of our organic comparisons more year-over-year I'll a Technology favorable in categories driven by our by Advanced were sales year. partially quarter year-over-year in and were product on selected Solutions return to in segment, a compared translation was of sales offset down Industrial Currency Precision decrease segment. X%, growth Solutions X% The cover the a and declines by the Solutions was prior our to segment challenging
related costs from of nonrecurring a in restructuring reflecting million a $XX prior up of the excludes basis during XXX Atrion percentage million, quarter, year to which acquisition parts higher of improvements about gross and basis. efficiency $XXX XX points, and factory costs basis sales points revenue. gains was onetime the was by profit, driven margin on the operating Adjusted This mix
end Selling, general expenses All growth a about administrative investment increased a year-over-year, company, is performance. percentage for points of XX% of and sales which this of targeted the continued in margin reflecting Atrion the represents operating front-end XX the addition on incremental as initiatives. basis and our high in,
our as That sales of initial integration X% of translates quarter. on quarter This operational for is also the above record a increased fourth to our prior million $XXX compares into the our over X% basis both profitability a of prior the quarter for really a the XX% XXX in This EBITDA target to million, articulated the year EBITDA XX% execution sales. incremental in long-term Atrion sales strong points $XXX fourth strategy. or overall quarter, Ascend year also and of growth acquisition. XX% at the
Looking quarter, to year. nonoperating at interest to nominally debt increase driven the higher in million. modest the by increased expenses quarter levels and the expense is net to due prior income This compared in $XX acquisitions
near to in X-year to increased term. which basis the year-over-year. The in net the balance purchase a pay finance the on million and price the year-over-year pension reminder, income million fluctuations Other in we $XXX September, our public funded accessed currency reduction revolver, debt in $X some notes a priced As primarily expense X.X% we with in of Atrion down at expect raising markets, to was order due acquisition.
rate of Tax expense $XX for million was effective the an quarter, tax XX%.
is our rate and full year tax reflects It approximately a a in bit will that structural mix acquisitions changes. cover continue due to of effective and see our quarter tax XX%. later. XXXX Naga This expected rate improved forward, in earnings changes fourth this other Our mix guidance reflected to going reflects of you'll
year. midpoint X% restructuring-related income expenses, totaled net share, and diluted $X.XX share acquisition or per prior while favorable that earnings differential $X.XX nonrecurring $XXX a the totaled guidance from GAAP quarter per I million were operating share per reflecting just the above over share, performance Adjusted $X.XX adjusted mentioned. contributions the excluding rate increase for and the strong tax of during equal our per earnings quarter, the
turn to X X% performance. fourth let's quarter the the favorable review impact acquisition Now prior of Organically, decreased segment sales and ARAG another the X% compared Slides to providing $XXX X% quarter million Precision currency of Industrial our X%. in year to X through decreased Solutions a fourth IPS quarter. with adding
IPS in delivered overall segment for our sales the driving decline comparisons the elevated in quarter. by for are processing that fourth and the deliveries polymer organic fiscal XXXX line year-over-year tough quarter the sales in recall the and You'll coatings create segment products. product record of driven record in industrial These IPS
year. For were XX% EBITDA the the $XXX lower full million with or the performance for flat sales sales, year, prior quarter was slightly reflecting sales. consistent of IPS organic on operational
partially in volume softness X% $X a compared sales Medical Fluid of benefit, year's was increased in $XXX a of and Atrion lines, minor acquisition the by fluid product lines. XX% in to some modest X. organic dispense volume improvement components solutions and organic quarter. Slide decrease product our fluid sales fourth or interventional million. by decline offset This medical offset by The increase reflects a currency and million Solutions to Turning prior primarily driven the
XX% was million were sales. EBITDA the inclusion or the of Fourth acquired XX% $XX due compared year margins of prior to to the or slightly EBITDA $XX which increase than of business. quarter EBITDA of XX% of million year an prior sales, the lower is Atrion
implement business we You'll and to time Atrion's over our EBITDA NBS framework. we as recall that integrate continue expect margins the growth improve Next to
to Turning X. Slide
to compared benefit. a You'll Technology X% increased quarter. currency prior Solutions increase fourth see included sales as well Advanced an $XXX sales X% change organic the volume of million This in small year's of as
driven as the and well product selected in inspection modest improvement by quarter as within lines was our test lines. electronics in Growth improvement dispense product
third improvement quarter electronics in ATS year-over-year semiconductor since reflect show to the a the seen markets of segment sales We've quarter and signs nominal improvement. sequential fiscal this end Our continue stable growth XXXX. continued time and return to in first the of for first from
as sales. sales, of really EBITDA particularly an it million growth. positions with and increase million cycle step-up Fourth quarter quarter from $X was of in the performance. the XX% to historical the from EBITDA $XX segment's a when efforts EBITDA testament year performance prior performance, base It's well XX% We're the margin EBITDA $XX down or a team's to electronics significant fourth business, or of XX% more million of us pleased represents markets meaningful a of improve the to the the structure return
from X% X. year's full decrease results. sales year turning a X% acquisitions, full increase previous of results. driven I'll record billion, an This the a sales X%. share XXXX compared year was our on an by a Slide impact to offset to comments by $X.X few were prior organic record of Now
sales did see Advanced On by improve decrease we as Fluid is a on The the combined all orders sales continue and product Technology organic full to our year for ATS with industrial and basis medical Solutions, driven essentially exited basis, although Solutions Medical were in the down organically slightly segment, flat year. XXXX. up lines essentially Solutions slightly segments a Industrial Precision we and our
year comparable of full it year EBITDA a million a year $XXX record And of solid incremental X% of or Ascend sales. which delivering sales, increased million represents XX%. or of profit for operating the This to the prior Adjusted consecutive EBITDA fourth XX% year. was XX% $XXX was the EBITDA marks to full the strategy, growth. margin
the the per And GAAP year, from diluted reflecting and a with share adjusted X% October On earnings we near-term ARAG we higher how the Atrion certain XXXX the our weakness diluted per we're year. confident were our at for and costs interest in associated decrease remain acquisitions. established the earnings end $X.XX, share $X.XX Investor prior targets balance, despite in Day. year X-year pleased with some finished markets, were
flow had net a the sheet in on million generating flow to cash another turning $XXX flow cash rate XX. of free income. on strong XXX% cash We Finally, balance conversion at Slide year, and
capital While of still working capital, additional both cash to was down from which and going expect forward. normalize strong, due flow was higher investments to And XXXX. this we of use conversion
in balance the While cash we quarter debt due deploy acquisition, increased Atrion to continue to efficiently. our the
During we XX%, annual annual by marking increased consecutive year our dividend XXst quarter, increases. the our of
of sheet $X.X of targeted of on billion, leverage the impact resulting line Through full shares open year million a of we a and at million a excluding our repaid net paid our This $XXX and with based XX-month the with within in range X.Xx our long-term in EBITDA. of approximately and the also ratio Atrion on repurchased of strong expectations for debt, market. year deployment, ended million with On strategic is year. acquisition, debt the million balances balance we cash trailing the $XXX $XX out $XXX dividends capital basis,
with our continue positive conversion demand. IPS deliver came business, line balance And in closing, guidance. with for in very in operational to and show summarize, an from in And segment better sheet, fourth our and demand some a pleased segments positioning product overall fiscal XXXX. our steadily previous Advanced we selected ourselves Technology improvement standpoint. near-term quarter to our a closed performance of lines. see signs we profit So just strong to We're We MFS were sales continue in well in weakness XXXX strong the dynamic despite to reinvested
now call to turn I'll Naga. the back